Literature DB >> 1841025

Development and progression of aortic valve stenosis: atherosclerosis risk factors--a causal relationship? A clinical morphologic study.

E R Mohler1, M J Sheridan, R Nichols, W P Harvey, B F Waller.   

Abstract

Hospital records of 120 patients undergoing aortic valve replacement were retrospectively reviewed for risk factors associated with early aortic valve replacement. Patients were separated into four groups (rheumatic, congenital bicuspid, degenerative, and miscellaneous) based upon the morphologic etiology of aortic stenosis. Multiple regression analysis was performed using age at surgery as the dependent variable. Independent variables for the study were race, gender, systemic hypertension, total triglyceride level, total serum cholesterol level, tobacco smoking history, diabetes mellitus, and angiographic coronary artery disease. In the rheumatic valve group only race showed a statistically significant risk effect whereas in the congenital bicuspid valve group race, gender, and triglycerides were statistically correlated with age at surgery. In the degenerative valve group gender and smoking were found to be statistically significant risk factors. The establishment of aortic stenosis risk factors might be an indication for clinical trials of risk factor modification in patients with aortic stenosis.

Entities:  

Mesh:

Year:  1991        PMID: 1841025     DOI: 10.1002/clc.4960141210

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  44 in total

1.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

2.  Administration of angiotensin-converting enzyme inhibitors is associated with slow progression of mild aortic stenosis in Japanese patients.

Authors:  Kana Wakabayashi; Takeshi Tsujino; Yoshiro Naito; Akira Ezumi; Masaaki Lee-Kawabata; Shinji Nakao; Akiko Goda; Yasushi Sakata; Kazuhiro Yamamoto; Takashi Daimon; Tohru Masuyama
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

3.  Aortic stenosis: An update.

Authors:  Sangeetha Nathaniel; Shreyas Saligram; Antony Leslie Innasimuthu
Journal:  World J Cardiol       Date:  2010-06-26

Review 4.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

Review 5.  Statins and aortic stenosis progression: are biologic targets still an option?

Authors:  Ramdas G Pai
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

6.  Etiology of bicuspid aortic valve disease: Focus on hemodynamics.

Authors:  Samantha K Atkins; Philippe Sucosky
Journal:  World J Cardiol       Date:  2014-12-26

Review 7.  Aortic valve sclerosis as a marker of active atherosclerosis.

Authors:  Kelley R Branch; Kevin D O'Brien; Catherine M Otto
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

Review 8.  Serotonin receptors and heart valve disease--it was meant 2B.

Authors:  Joshua D Hutcheson; Vincent Setola; Bryan L Roth; W David Merryman
Journal:  Pharmacol Ther       Date:  2011-04-02       Impact factor: 12.310

Review 9.  Shear-Sensitive Genes in Aortic Valve Endothelium.

Authors:  Joan Fernández Esmerats; Jack Heath; Hanjoong Jo
Journal:  Antioxid Redox Signal       Date:  2016-01-21       Impact factor: 8.401

10.  Association of aortic valve sclerosis and coronary artery disease in patients with severe nonischemic mitral regurgitation.

Authors:  Andrea Rossi; Gerald Bertagnolli; Mariantonietta Cicoira; Giorgio Golia; Luisa Zanolla; Francesco Santini; Claudio Cemin; Gabriele Ferrario; Piero Zardini
Journal:  Clin Cardiol       Date:  2003-12       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.